<DOC>
	<DOCNO>NCT01497535</DOCNO>
	<brief_summary>This trial conduct Europe . The aim trial compare within-subject variability insulin detemir another basal insulin analogue , insulin glargine healthy volunteer .</brief_summary>
	<brief_title>Within-subject Variability Insulin Detemir Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Healthy Japanese men woman Holding Japanese passport Japaneseborn parent Considered generally healthy upon completion medical history physical examination judge Investigator Body Mass Index ( BMI ) 18 30 kg/m^2 , incl . Fasting blood glucose maximum 6 mmol/L Clinically significant abnormal haematology biochemistry screen test , judge Investigator Any serious systemic infectious disease occur four week prior first dose trial product , judge Investigator Subject history alcohol drug dependence</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>